Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-26-001737
Filing Date
2026-03-12
Accepted
2026-03-12 17:00:51
Documents
69
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2025 xenetic_i10k-123125.htm   iXBRL 10-K 1314597
2 FOURTH AMENDMENT TO RESEARCH FUNDING AND OPTION AGREEMENT xenetic_ex1023.htm EX-10.23 105623
3 FIRST AMENDMENT TO CONSULTING AGREEMENT, DATED DECEMBER 31, 2025 xenetic_ex1025.htm EX-10.25 14357
4 LIST OF SUBSIDIARIES xenetic_ex2101.htm EX-21.1 3207
5 CONSENT OF MARCUM LLP xenetic_ex2301.htm EX-23.1 1658
6 CONSENT OF CBIZ CPAS P.C. xenetic_ex2302.htm EX-23.2 1737
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_ex3101.htm EX-31.1 10690
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_ex3102.htm EX-31.2 10658
9 CERTIFICATION xenetic_ex3201.htm EX-32.1 4082
15 GRAPHIC pic1.jpg GRAPHIC 51052
  Complete submission text file 0001683168-26-001737.txt   6046937

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE xbio-20251231.xsd EX-101.SCH 30704
11 XBRL CALCULATION FILE xbio-20251231_cal.xml EX-101.CAL 37323
12 XBRL DEFINITION FILE xbio-20251231_def.xml EX-101.DEF 203724
13 XBRL LABEL FILE xbio-20251231_lab.xml EX-101.LAB 360857
14 XBRL PRESENTATION FILE xbio-20251231_pre.xml EX-101.PRE 321001
72 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10k-123125_htm.xml XML 700884
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 26748789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)